Dr. Roman Salasznyk leads Booz Allen’s life science practice, as well as its support to the U.S. Food and Drug Administration and the National Institutes of Health. Based out of our Rockville, Maryland office, he is a recognized leader in the pharmaceutical development lifecycle, including the management of nonclinical, clinical, and manufacturing studies; supporting transformational change through the delivery of leading-edge informatics capabilities; and integrating broad disciplines within life sciences to support federal health clients.
Roman has more than 16 years of experience in biomedical research, medical product and regulatory lifecycle development, and general management consulting. At Booz Allen, he manages a multidisciplinary team that supports initiatives aimed at expediting medical product approvals and scientific discoveries, fostering innovative research and strategies to improve public health, and strengthening the efficiency and effectiveness of mission-critical operations.
Prior to joining Booz Allen in 2010, Roman managed the clinical and regulatory development of cellular therapies to treat serious medical conditions for inflammatory, orthopedic, and cardiovascular indications at Osiris Therapeutics. His work included leading the company’s development of a biological product under a multimillion-dollar Department of Defense contract.
Roman is a certified project management professional. He was an Aspen Spotlight Health Scholar, has authored more than 10 peer-reviewed scientific publications, and holds a U.S. patent for the preparation and delivery of cellular therapeutics.
He has a Ph.D. in biology from Rensselaer Polytechnic Institute.
